Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
13.82 +0.20 (+1.47%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 13.82 unch (unch) 16:44 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
13.56
Day High
13.84
Open 13.65
Previous Close 13.62 13.62
Volume 3,366,100 3,366,100
Avg Vol 2,962,395 2,962,395
Stochastic %K 24.46% 24.46%
Weighted Alpha +19.53 +19.53
5-Day Change -0.05 (-0.36%) -0.05 (-0.36%)
52-Week Range 9.74 - 14.63 9.74 - 14.63
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,689,847
  • Shares Outstanding, K 124,071
  • Annual Sales, $ 277,250 K
  • Annual Income, $ 27,310 K
  • EBIT $ -4 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.23
  • Price/Sales 6.10
  • Price/Cash Flow 86.14
  • Price/Book 3.00

Options Overview Details

View History
  • Implied Volatility 46.67% ( +9.21%)
  • Historical Volatility 26.78%
  • IV Percentile 78%
  • IV Rank 34.70%
  • IV High 113.17% on 12/31/24
  • IV Low 11.34% on 09/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 155
  • Volume Avg (30-Day) 250
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 13,888
  • Open Int (30-Day) 12,364

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +142.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.15 +5.10%
on 02/24/25
Period Open: 13.33
14.63 -5.54%
on 03/07/25
+0.49 (+3.68%)
since 02/21/25
3-Month
11.81 +17.02%
on 02/11/25
Period Open: 12.72
14.63 -5.54%
on 03/07/25
+1.10 (+8.65%)
since 12/20/24
52-Week
9.74 +41.89%
on 08/06/24
Period Open: 12.16
14.63 -5.54%
on 03/07/25
+1.66 (+13.65%)
since 03/21/24

Most Recent Stories

More News
Why Dynavax Technologies (DVAX) Stock Might be a Great Pick

One stock that might be an intriguing choice for investors right now is Dynavax Technologies Corporation DVAX. This is because this security in the Medical - Biomedical and Genetics space is seeing solid...

DVAX : 13.82 (+1.47%)
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript

DVAX earnings call for the period ending December 31, 2024.

DVAX : 13.82 (+1.47%)
Dynavax Technologies: Q4 Earnings Snapshot

Dynavax Technologies: Q4 Earnings Snapshot

DVAX : 13.82 (+1.47%)
Implied Volatility Surging for Dynavax Technologies (DVAX) Stock Options

Investors in Dynavax Technologies Corporation DVAX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $3 Call had some of the highest...

DVAX : 13.82 (+1.47%)
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?

Investors in Dynavax Technologies Corporation DVAX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $03.00 Call had some of the highest...

DVAX : 13.82 (+1.47%)
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript

DVAX earnings call for the period ending September 30, 2024.

DVAX : 13.82 (+1.47%)
Dynavax Technologies: Q3 Earnings Snapshot

Dynavax Technologies: Q3 Earnings Snapshot

DVAX : 13.82 (+1.47%)
Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript

DVAX earnings call for the period ending June 30, 2024.

DVAX : 13.82 (+1.47%)
Dynavax Technologies: Q2 Earnings Snapshot

Dynavax Technologies: Q2 Earnings Snapshot

DVAX : 13.82 (+1.47%)
3 'Strong Buy' Small-Caps With 27% to 146% Upside Potential

This article highlights three small-cap stocks with 'Strong Buy' ratings that offer substantial upside potential of 27% to 146% and are poised to benefit from current market trends.

HI : 25.77 (-1.72%)
HLX : 8.61 (-0.35%)
DVAX : 13.82 (+1.47%)
$IQY : 1,287.57 (-0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

3rd Resistance Point 14.19
2nd Resistance Point 14.01
1st Resistance Point 13.92
Last Price 13.82
1st Support Level 13.64
2nd Support Level 13.46
3rd Support Level 13.37

See More

52-Week High 14.63
Last Price 13.82
Fibonacci 61.8% 12.76
Fibonacci 50% 12.18
Fibonacci 38.2% 11.61
52-Week Low 9.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals